These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31451545)

  • 1. Robust Suppression of Lipopolysaccharide Deficiency in Acinetobacter baumannii by Growth in Minimal Medium.
    Nagy E; Losick R; Kahne D
    J Bacteriol; 2019 Nov; 201(22):. PubMed ID: 31451545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acinetobacter baumannii Can Survive with an Outer Membrane Lacking Lipooligosaccharide Due to Structural Support from Elongasome Peptidoglycan Synthesis.
    Simpson BW; Nieckarz M; Pinedo V; McLean AB; Cava F; Trent MS
    mBio; 2021 Dec; 12(6):e0309921. PubMed ID: 34844428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-β-1,6-N-acetylglucosamine.
    Henry R; Vithanage N; Harrison P; Seemann T; Coutts S; Moffatt JH; Nation RL; Li J; Harper M; Adler B; Boyce JD
    Antimicrob Agents Chemother; 2012 Jan; 56(1):59-69. PubMed ID: 22024825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the paradigm for the outer membrane: Acinetobacter baumannii in the absence of endotoxin.
    Powers MJ; Trent MS
    Mol Microbiol; 2018 Jan; 107(1):47-56. PubMed ID: 29114953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an Acinetobacter baumannii lptD Deletion Strain: Permeability Defects and Response to Inhibition of Lipopolysaccharide and Fatty Acid Biosynthesis.
    Bojkovic J; Richie DL; Six DA; Rath CM; Sawyer WS; Hu Q; Dean CR
    J Bacteriol; 2015 Dec; 198(4):731-41. PubMed ID: 26668262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homeoviscous Adaptation of the Acinetobacter baumannii Outer Membrane: Alteration of Lipooligosaccharide Structure during Cold Stress.
    Herrera CM; Voss BJ; Trent MS
    mBio; 2021 Aug; 12(4):e0129521. PubMed ID: 34425709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of
    VanOtterloo LM; Macias LA; Powers MJ; Brodbelt JS; Trent MS
    mBio; 2024 Mar; 15(3):e0301323. PubMed ID: 38349180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The
    Kamischke C; Fan J; Bergeron J; Kulasekara HD; Dalebroux ZD; Burrell A; Kollman JM; Miller SI
    Elife; 2019 Jan; 8():. PubMed ID: 30638443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipid retention in the absence of asymmetry strengthens the outer membrane permeability barrier to last-resort antibiotics.
    Powers MJ; Trent MS
    Proc Natl Acad Sci U S A; 2018 Sep; 115(36):E8518-E8527. PubMed ID: 30087182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acinetobacter baumannii outer membrane protein A modulates the biogenesis of outer membrane vesicles.
    Moon DC; Choi CH; Lee JH; Choi CW; Kim HY; Park JS; Kim SI; Lee JC
    J Microbiol; 2012 Feb; 50(1):155-60. PubMed ID: 22367951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.
    Carretero-Ledesma M; García-Quintanilla M; Martín-Peña R; Pulido MR; Pachón J; McConnell MJ
    Virulence; 2018 Dec; 9(1):930-942. PubMed ID: 29638177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii.
    Boll JM; Crofts AA; Peters K; Cattoir V; Vollmer W; Davies BW; Trent MS
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6228-E6237. PubMed ID: 27681618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-based screen for discovering lipopolysaccharide biogenesis inhibitors.
    Zhang G; Baidin V; Pahil KS; Moison E; Tomasek D; Ramadoss NS; Chatterjee AK; McNamara CW; Young TS; Schultz PG; Meredith TC; Kahne D
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):6834-6839. PubMed ID: 29735709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation and Suppressor Analysis of the Essential Lipopolysaccharide Transport Protein LptA Reveals Strategies To Overcome Severe Outer Membrane Permeability Defects in Escherichia coli.
    Falchi FA; Maccagni EA; Puccio S; Peano C; De Castro C; Palmigiano A; Garozzo D; Martorana AM; Polissi A; Dehò G; Sperandeo P
    J Bacteriol; 2018 Jan; 200(2):. PubMed ID: 29109183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic Accumulation of LPS Pathway Intermediates Underlies the Requirement of LpxH for Growth of Acinetobacter baumannii ATCC 19606.
    Richie DL; Takeoka KT; Bojkovic J; Metzger LE; Rath CM; Sawyer WS; Wei JR; Dean CR
    PLoS One; 2016; 11(8):e0160918. PubMed ID: 27526195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lytic transglycosylase contributes to the survival of lipooligosaccharide-deficient, colistin-dependent Acinetobacter baumannii.
    Lee JY; Lee H; Park M; Cha CJ; Shin D; Ko KS
    Clin Microbiol Infect; 2019 Sep; 25(9):1156.e1-1156.e7. PubMed ID: 30790686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the essentiality of lipopolysaccharide to Gram-negative bacteria.
    Zhang G; Meredith TC; Kahne D
    Curr Opin Microbiol; 2013 Dec; 16(6):779-85. PubMed ID: 24148302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with lipopolysaccharide-free outer membrane complexes protects against Acinetobacter baumannii infection.
    Pulido MR; García-Quintanilla M; Pachón J; McConnell MJ
    Vaccine; 2018 Jul; 36(29):4153-4156. PubMed ID: 29887323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo-validated essential genes identified in Acinetobacter baumannii by using human ascites overlap poorly with essential genes detected on laboratory media.
    Umland TC; Schultz LW; MacDonald U; Beanan JM; Olson R; Russo TA
    mBio; 2012; 3(4):. PubMed ID: 22911967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose availability enhances lipopolysaccharide production and immunogenicity in the opportunistic pathogen Acinetobacter baumannii.
    Rossi E; Longo F; Barbagallo M; Peano C; Consolandi C; Pietrelli A; Jaillon S; Garlanda C; Landini P
    Future Microbiol; 2016; 11(3):335-49. PubMed ID: 26934424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.